In summary, our study compellingly illustrates that the overexpressed METTL3 in ESCC, the major methyltransferase catalyzing m6A modification of mRNA, disrupts the delicate balance of m6A modification. The gene discussed is METTL3; the disease is esophageal squamous cell carcinoma.